| [1] |
Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy Outcomes in Women with Cardiovascular Disease: Evolving Trends over 10 Years in the ESC Registry Of Pregnancy And Cardiac Disease (ROPAC)[J]. European Heart Journal, 2019, 40(47): 3848-3855.
|
| [2] |
朱丽均，秦敏，朱蓉，等．上海市近10年危重孕产妇疾病谱分析[J]．中国妇幼保健，2018,33(22):5046-5049.
|
| [3] |
ACOG. ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease [J]. Obstetrics & Gynecology, 2019, 133(5): e320-e356.
|
| [4] |
邱进，刘辉，热孜宛古丽·伊敏，等. MEF2C基因启动子区碱基突变对转录活性的影响[J]. 新疆医科大学学报，2017,05:606-616.
|
| [5] |
中华医学会妇产科学分会产科学组. 妊娠合并心脏病的诊治专家共识(2016)[J]. 中华妇产科杂志，2016, 51(6):401-409.
|
| [6] |
郑兴，吴兆红. 妊娠合并先天性心脏病的诊疗进展[J]. 中华产科急救电子杂志，2018, 7(4):243-246.
|
| [7] |
Troiano NH, Witcher PM. Maternal Mortality and Morbidity in the United States: Classification, Causes, Preventability, and Critical Care Obstetric Implications[J]. The Journal of Perinatal & Neonatal Nursing, 2018, 32(3): 222-231.
|
| [8] |
张军. 妊娠合并心脏病的多学科(分层)管理[J]. 中国全科医学，2019, 22(3):10-15.
|
| [9] |
凡姝，耿力. 妊娠合并肺动脉高压52例临床特点分析[J]. 现代妇产科进展，2020,2:134-140.
|
| [10] |
黄燕洁，王晓云，刘沛珍. 77例妊娠合并心脏病伴肺动脉高压患者的母婴结局及护理对策[J]. 临床医学工程，2019,12:1703-1704.
|
| [11] |
薛玉前，刘毓华，安秀成. 少见的妊娠合并动脉导管未闭1例[J]. 中国医药指南，2011,16:329.
|
| [12] |
许咏乐，孟庆霞，邹琴燕，等. 20例嵌合型Turner综合征的辅助生殖助孕及相关文献复习[J]. 生殖医学杂志，2018,11:1120-1125.
|
| [13] |
Sanghavi M, Rutherford JD. Cardiovascular Physiology of Pregnancy[J]. Circulation, 2014, 130(12): 1003-1008.
|
| [14] |
Burlingame JM, Yamasato K, Ahn HJ, et al. B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy[J]. Journal of Perinatal Medicine, 2017, 45(5).
|
| [15] |
Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study[J]. Circulation, 2007, 115(24): 3103-10.
|
| [16] |
Januzzi JL, Chen-Tournoux AA, Christenson RH, et al. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department[J]. Journal of the American College of Cardiology, 2018, 71(11).
|
| [17] |
Hameed AB, Chan K, Ghamsary M, et al. Longitudinal Changes in the B-Type Natriuretic Peptide Levels in Normal Pregnancy and Postpartum[J]. Clinical Cardiology, 2009, 32(8): E60-E62.
|
| [18] |
ACOG. Guidelines for diagnostic imaging during pregnancy and lactation. Committee Opinion No. 723. American College of Obstetrics and gynecology，2017,130(4):e210-e216.
|
| [19] |
Easterling T, Mundle S, Bracken H, et al. Oral Antihypertensive Regimens (Nifedipine Retard, Labetalol, and Methyldopa) for Management of Severe Hypertension in Pregnancy: An Open-Label, Randomised Controlled Trial[J]. The Lancet, 2019, 394(10203): 1011-1021.
|
| [20] |
Gainder S, Thakur M, Saha SC, et al. To Study the Changes in Fetal Hemodynamics with Intravenous Labetalol or Nifedipine in Acute Severe Hypertension[J]. Pregnancy Hypertension, 2019, 15: 12-15.
|
| [21] |
Karahanoglu E, Altinboga O, Akpinar F, et al. Nifedipine Increases Fetoplacental Perfusion[J]. Journal of Perinatal Medicine, 2017, 45(1): 51-55.
|
| [22] |
Bolinick AD, Bolnick JM, Kohan-Ghadr HR, et al. Nifedipine Prevents Apoptosis of Alcohol-Exposed First-Trimester Trophoblast Cells[J]. Alcoholism: Clinical and Experimental Research, 2018, 42(1): 53-60.
|
| [23] |
Wright JM, Page RL, Field ME. Antiarrhythmic Drugs in Pregnancy[J]. Expert Review of Cardiovascular Therapy, 2015, 13(12): 1433-1444.
|
| [24] |
Chauveau S, Le Vavasseur O, Morel E, et al. Flecainide Is a Safe and Effective Treatment for Pre-Excited Atrial Fibrillation Rapidly Conducted to the Ventricle in Pregnant Women: A Case Series[J]. European Heart Journal. Case Reports, 2019, 3(2).
|
| [25] |
浦介麟，吴林，吴永全，等. 索他洛尔抗心律失常中国专家共识[J]. 中国循环杂志，2019(8).
|
| [26] |
Bateman BT, Patorno E, Desai RJ, et al. Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia[J]. Pediatrics, 2016, 138(3).
|
| [27] |
Sharma C, Soni A, Gupta A, et al. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial[J]. American Journal of Obstetrics & Gynecology, 2017, 217(6):687.e1-687.e6.
|
| [28] |
Pieper PG. Use of Medication for Cardiovascular Disease during Pregnancy[J]. Nature Reviews Cardiology, 2015, 12(12): 718-729.
|
| [29] |
Brown RA, Spina D, Page CP. Adenosine Receptors and Asthma[J]. British Journal of Pharmacology, 2008, 153 Suppl 1: S446-456.
|
| [30] |
Martin-Suarez A, Sanchez-Hernandez JG, Mmedina-Barajas F, et al. Pharmacokinetics and Dosing Requirements of Digoxin in Pregnant Women Treated for Fetal Supraventricular Tachycardia[J]. Expert Review of Clinical Pharmacology, 2017, 10(8): 911-917.
|
| [31] |
Silversides CK, Grewal J, Mason J, et al. Pregnancy Outcomes in Women With Heart Disease[J]. Journal of the American College of Cardiology, 2018, 71(21): 2419-2430.
|
| [32] |
中华医学会心血管病学分会，中国老年学学会心脑血管病专业委员会. 华法林抗凝治疗的中国专家共识[J]. 中华内科杂志，2013, 52(1):76-82.
|
| [33] |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. 2017:252-289.
|
| [34] |
Alshawabkeh L, Economy KE, Valente AM. Anticoagulation During Pregnancy [J]. Journal of the American College of Cardiology, 2016, 68(16): 1804-1813.
|
| [35] |
Jindal R, Bajwa SK, Bajwa SJS, et al. Pregnancy in cardiac disease: clinical, obstetric and anaesthetic concerns[J]. Sri Lanka Journal of Obstetrics and Gynaecology, 2012, 33(4): 174.
|
| [36] |
Chen XQ, Wu SH, Guo XR, et al. Effects of Antenatal Application of Ambroxol and Glucocorticoid on Lung Morphometry and Signal Transduction of Bone Morphogenetic Protein in the Fetal Rat[J]. Molecular Medicine Reports, 2012, 6(1): 63-68.
|
| [37] |
张敏. 我国孕产妇死亡率的影响因素及预测研究[D]. 山东大学，2014.
|
| [38] |
Magnusson P, Gabriella Kihlström, Wallhagen M, et al. Life-threatening peripartum cardiomyopathy-Not expected when expecting[J]. Clinical Case Reports, 2019,.7(6):1127-1132.
|
| [39] |
Blauwet LA, Cooper LT. Diagnosis and management of peripartum cardiomyopathy[J]. Heart, 97(23):1970-1981.
|